The Daily Papule

Meeting abstracts

BAD 2026

British Association of Dermatologists · Manchester, 30 June – 2 July 2026

639 abstracts, published in BJD on 26 June 2026.

  1. BC01

    Daily photoprotection with an antioxidant-enriched sunscreen preserves mitochondrial DNA integrity in facial skin in vivo: a randomized, double-blind, vehicle-controlled trial

    Khalil A, Fassihi H, … senior author Craythorne E

  2. BC05

    Money in melanotan

    Hegazy S, Ridge A

  3. BH14

    Fibrosing alopecia in a patterned distribution following photodynamic therapy for actinic keratosis: a potential trigger for scarring alopecia

    Ra A, Harries M

  4. BI31

    Daylight photodynamic therapy as an effective treatment for extensive verrucae vulgares in a renal transplant recipient

    Najafi K, Jackson E, Bogucki P

  5. BI35

    Skin-focused safety measures in upadacitinib-treated inflammatory bowel disease: a service evaluation

    Kuladeva D, Zhen Yam AI, Paul Seenan J

  6. BI38

    Methotrexate-associated lymphoma in atopic dermatitis: two case reports

    Eid D, Ponnambath N

  7. BI43

    A high-risk squamous cell carcinoma developing in a patient with eczema treated with upadacitinib

    Murphy L, McCafferty B, … senior author McKenna D

  8. GD02

    Understanding risk factors to strengthen skin cancer surveillance programmes for people with albinism in East Africa

    Roberts E, Mataiga R, … senior author Freeland H

  9. GD12

    Tinea indotineae complicating and potentially propagated by psoriasis

    Illango A, Montgomery R, … senior author Muinonen-Martin A

  10. HX08

    From ‘children who burn in sunlight’ to DNA repair defect: xeroderma pigmentosum and the birth of molecular dermatology

    McGarel S, Da Silva F, … senior author Fleming S

  11. LY13

    A confirmatory phase III multicentre, randomized, double-blind, placebo-controlled study of the efficacy of topical HyBryte™ (hypericin sodium) and visible-light activation for the treatment of cutaneous T-cell lymphoma: interim analysis results of primary efficacy and safety for FLASH2

    Scarisbrick J, Vermeer M, … senior author Pullion C

  12. LY20

    Cutaneous lymphoma in the post-transplant setting

    Cooke A, Ieremia E, Matin RN

  13. LY23

    Granulomatous mogamulizumab-associated rash mimicking disease progression in erythrodermic mycosis fungoides

    Victory L, Fagan N, … senior author Molloy K

  14. P019

    Palbociclib-induced subacute cutaneous lupus erythematosus: a rare clinicopathological case

    Shah S, Nagendra S, … senior author Shahid A

  15. P023

    Acquired reactive perforating collagenosis in the setting of newly diagnosed primary biliary cholangitis

    Ali S, Brady R, … senior author Flynn A

  16. P033

    Toxic epidermal necrolysis-like lupus treated with etanercept

    Ralph J, Gaffney A, … senior author Alsharqi A

  17. P098

    Cutaneous adverse effects of pirfenidone in an Irish cohort: the role of sun protection education

    Zagoneanu AE, Lim J, … senior author Henry M

  18. P102

    Repigmentation and disease stabilization across medical, phototherapeutic and surgical treatments in vitiligo: a systematic review and meta-analysis

    Parsad D, Kumaran S, Keshavamurthy V

  19. P174

    Variations in sun protection guidance issued by governments in countries with high and low skin cancer incidence

    Ibrahim H, Moura W, … senior author Janakan G

  20. P175

    Sunlight exposure, vitamin D benefit and DNA damage harm: a systematic review of human experimental studies across skin phototypes

    Nolan C, Khasati A, … senior author Rhodes L

  21. P180

    Young adults’ perspectives on sunbed tanning alternatives: examining facilitators and barriers in a UK sample

    Rodrigues A, Hoult L, … senior author Court P

  22. P182

    Role of bone morphogenetic protein-4 signalling and its natural inhibitors with narrowband ultraviolet B phototherapy in patients with nonsegmental vitiligo

    Pilkhwal N, Kumar V, … senior author Parsad D

  23. P185

    Development and evaluation of a wearable optical sensor for personalized patient dosimetry in daylight photodynamic therapy

    Maher S, McCavana J, … senior author Cody D

  24. P198

    Identifying risk factors for melanoma in patients aged < 50 years: a retrospective observational study from a UK district dermatology service

    Kiridaran V, Rinaldi G, … senior author Barkham M

  25. P202

    Indoor vs. outdoor daylight photodynamic therapy for multiple actinic keratoses: a weatherproof approach

    Liew SY, Bridgewater K, … senior author Patel GK

  26. PA07

    Sun-safety policies in UK schools

    McHardy J, George S, McNulty-Brown E

  27. PA08

    Primary prevention of skin cancer during early childhood in Ireland

    Byrne B, Bower S, … senior author Cotter C

  28. PD01

    Targeted phototherapy with monochromatic excimer light is not efficacious in the management of residual vitiligo patches following whole-body narrowband ultraviolet B light therapy: an open-label, prospective study

    Mehta N, Khandpur S, … senior author Sahni K

  29. PD02

    Molecular responses of human skin to single and repeated low-dose ultraviolet radiation exposure

    Peake M, Rutter K, … senior author Rhodes L

  30. PD03

    Drug-induced photosensitivity: a 10-year review from a tertiary photodiagnostic service

    Demirel S, Ibbotson S

  31. PD04

    Clinical spectrum and outcomes in a cohort of patients with trichothiodystrophy: a single-centre experience

    White J, Sellar P, … senior author Paolino A

  32. PD05

    Xeroderma pigmentosum complementation group C: a retrospective observational study of 46 patients reveals skin cancer heterogeneity dependent on the level of nucleotide excision DNA repair

    Theocharopoulos I, Balgos K, … senior author Fassihi H

  33. PD08

    Photopatch testing and photodiagnostic investigations in a tertiary photodiagnostic service: a 5-year review

    Li C, Ibbotson S

  34. PD10

    The Photoaggravated Eczema Area and Severity Index: development and reliability of a clinical measure for photoaggravated atopic dermatitis

    Warner-Levy J, Downs N, … senior author Ayer J

  35. PD11

    Home phototherapy: one centre’s experience over the last 12 years

    Montgomery R, Britton J, Goulden V

  36. PD12

    Early tanners, higher risk: when sunbed use becomes the norm in Scotland

    Yerdelen A, Perkins A, … senior author Danduri H

  37. PD13

    Evaluating a smartphone-based solar exposure tool for supporting management of photodermatoses

    Eadie E, Hamilton K, … senior author Ibbotson S

  38. PD14

    Characteristics and claims of top-selling sunscreens in the UK

    Khoda F, Sindhoo Z, Rutter K

  39. PD15

    Predicting psoriasis response to ultraviolet B phototherapy: how much do missed appointments and early treatment response impact outcome?

    Jand A, Arslan H, … senior author Weatherhead S

  40. PD16

    Gaps in understanding of photoprotection in dermatology patients: what information should we be giving our patients?

    Shaw R, Rujeedawa M, Weatherhead S

  41. PD17

    From garden to GeoDome: delivering reliable daylight photodynamic therapy in a UK hospital

    Ali H, Nevitte L, … senior author Keith D

  42. PD18

    Ultraviolet A1 phototherapy is an effective treatment for fibrotic skin conditions and granuloma annulare: a retrospective case series of 67 patients treated at a tertiary photodermatology unit

    Shetty M, Fassihi H, … senior author Novakovic L

  43. PD19

    Phototherapy narrowband ultraviolet minimal erythema dose testing: recommendations for handheld minimal erythema dose units

    Britton J, Brown J, … senior author Verma P

  44. PD20

    The impact of circadian rhythm on phototherapy treatment in psoriasis

    Tan YL, Armstrong V, … senior author Weatherhead S

  45. PD21

    Investigating the role of narrowband ultraviolet B phototesting in general dermatology

    McKeever J, Eadie E, … senior author Ibbotson S

That's every abstract.